Merck price target raised to $136 from $120 at Scotiabank

Scotiabank raised the firm’s price target on Merck (MRK) to $136 from $120 and keeps an Outperform rating on the shares. The firm’s increase in price target is driven by multiple expansion as the company’s execution continues to exceed the Scotiabank’s expectations, the analyst tells investors.